Published in Infect Control Hosp Epidemiol on April 01, 2011
Current status of Clostridium difficile infection epidemiology. Clin Infect Dis (2012) 3.14
Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis (2012) 1.96
Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol (2014) 1.73
Depression, antidepressant medications, and risk of Clostridium difficile infection. BMC Med (2013) 1.54
Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol (2013) 1.52
Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries. J Am Coll Surg (2014) 1.49
Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe (2014) 1.40
Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis (2014) 1.28
Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One (2013) 1.24
Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist (2014) 1.21
Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates. Antimicrob Agents Chemother (2013) 1.19
Epidemiology of Clostridium difficile infection. J Pharm Pract (2013) 1.10
Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemiol (2013) 1.10
Clostridium difficile infection in the twenty-first century. Emerg Microbes Infect (2013) 1.09
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
Statewide costs of health care-associated infections: estimates for acute care hospitals in North Carolina. Am J Infect Control (2013) 0.97
Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth. PLoS One (2016) 0.96
Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther Adv Infect Dis (2016) 0.95
Immune responses to Clostridium difficile infection. Trends Mol Med (2012) 0.95
Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile. J Bacteriol (2012) 0.93
The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host. Microbiol Mol Biol Rev (2015) 0.92
Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrence. Antimicrob Agents Chemother (2013) 0.91
Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options. Scientifica (Cairo) (2014) 0.91
Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infect Immun (2013) 0.90
A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol (2013) 0.90
Hospital-acquired Clostridium difficile infections: estimating all-cause mortality and length of stay. Epidemiology (2014) 0.90
Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies. PLoS One (2015) 0.87
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent. Infect Control Hosp Epidemiol (2015) 0.87
Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens. Gut Microbes (2015) 0.86
Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan. Antimicrob Agents Chemother (2012) 0.86
Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens. J Clin Microbiol (2012) 0.85
MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation. Infect Immun (2012) 0.85
Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile. MBio (2015) 0.83
Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates. Infect Immun (2014) 0.83
Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol (2016) 0.82
Effects of surotomycin on Clostridium difficile viability and toxin production in vitro. Antimicrob Agents Chemother (2015) 0.82
A simulation-based assessment of strategies to control Clostridium difficile transmission and infection. PLoS One (2013) 0.82
Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe Complicated Clostridium difficile Infection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country. Gastroenterol Res Pract (2016) 0.81
Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther (2014) 0.81
Comparison of ChromID agar and Clostridium difficile selective agar for effective isolation of C. difficile from stool specimens. Ann Lab Med (2013) 0.81
Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tube. Drugs R D (2014) 0.81
Recurrent Clostridium difficile infections: the importance of the intestinal microbiota. World J Gastroenterol (2014) 0.79
Performance of severity of illness classification for Clostridium difficile infection to predict need-for-colectomy or inpatient death. J Community Hosp Intern Med Perspect (2014) 0.79
Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis. Arch Med Sci (2015) 0.79
Acid suppression and the risk of Clostridium difficile infection. J Pediatr (2013) 0.79
Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection. J Clin Gastroenterol (2016) 0.79
Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model. Antimicrob Agents Chemother (2015) 0.79
Kibdelomycin is a potent and selective agent against toxigenic Clostridium difficile. Antimicrob Agents Chemother (2014) 0.79
Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine (2015) 0.78
Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample. BMC Infect Dis (2015) 0.78
A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection. J Clin Gastroenterol (2016) 0.77
Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China. Infection (2017) 0.76
Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review. Geriatr Orthop Surg Rehabil (2012) 0.76
Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol (2015) 0.76
Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection. Infect Dis Rep (2015) 0.76
Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens. Ann Lab Med (2016) 0.76
Protein expression, characterization, crystallization and preliminary X-ray crystallographic analysis of a Fic protein from Clostridium difficile. Acta Crystallogr F Struct Biol Commun (2014) 0.76
Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole. Antimicrob Agents Chemother (2015) 0.75
Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire. J Clin Gastroenterol (2016) 0.75
An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model. PLoS One (2016) 0.75
A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection. Infect Control Hosp Epidemiol (2015) 0.75
Host response to Clostridium difficile infection: Diagnostics and detection. J Glob Antimicrob Resist (2016) 0.75
Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains. PLoS One (2017) 0.75
The microbiota and immune response during Clostridium difficile infection. Anaerobe (2016) 0.75
A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements. Antimicrob Agents Chemother (2017) 0.75
Fidaxomicin--the new drug for Clostridium difficile infection. Indian J Med Res (2015) 0.75
Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection. Anaerobe (2015) 0.75
Probiotics for Clostridium difficile infection in adults (PICO): Study protocol for a double-blind, randomized controlled trial. Contemp Clin Trials (2015) 0.75
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation. J Transl Med (2016) 0.75
Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection. Infect Dis Ther (2016) 0.75
Protection of hamsters from mortality by reducing fecal moxifloxacin concentration with DAV131A in a model of moxifloxacin-induced Clostridium difficile colitis. Antimicrob Agents Chemother (2017) 0.75
An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureus. Infect Dis (Auckl) (2017) 0.75
Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med (2002) 8.67
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis (2003) 4.06
The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol (2002) 3.77
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med (2013) 3.72
Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32
The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol (2011) 3.24
Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13
Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med (2002) 2.68
Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA (2013) 2.55
Poor functional status as a risk factor for surgical site infection due to methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2008) 2.33
A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.32
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30
Early predictors of in-hospital death in infective endocarditis. Circulation (2004) 2.26
The value of an infectious diseases specialist. Clin Infect Dis (2003) 2.12
Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep (2013) 2.06
Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res (2009) 2.03
Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2007) 1.89
Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84
Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81
Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol (2010) 1.79
Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis (2007) 1.78
The effect of increasing age on the risk of surgical site infection. J Infect Dis (2005) 1.75
Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol (2004) 1.74
Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol (2014) 1.67
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit. J Surg Res (2012) 1.58
Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat Biotechnol (2005) 1.49
Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss. Infect Control Hosp Epidemiol (2009) 1.38
Novel peptide inhibitors of angiotensin-converting enzyme 2. J Biol Chem (2003) 1.36
Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis (2003) 1.35
Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents. J Infect Dis (2008) 1.35
What's new in Rocky Mountain spotted fever? Infect Dis Clin North Am (2008) 1.33
Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am (2006) 1.29
Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS One (2009) 1.28
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J (2007) 1.26
Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis (2005) 1.26
The effect of surgical site infection on older operative patients. J Am Geriatr Soc (2009) 1.24
Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis (2009) 1.19
Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia. Am J Med (2005) 1.18
Risk factors for surgical site infection complicating laminectomy. Infect Control Hosp Epidemiol (2007) 1.17
Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol (2007) 1.16
The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin Infect Dis (2008) 1.16
Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med (2008) 1.16
Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009. J Infect Dis (2011) 1.15
Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med (2005) 1.14
Postoperative joint infections due to Propionibacterium species: a case-control study. Clin Infect Dis (2009) 1.14
Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging. Bioconjug Chem (2012) 1.12
Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. J Am Geriatr Soc (2014) 1.12
Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 1.10
Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. Infect Control Hosp Epidemiol (2013) 1.10
Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist (2012) 1.10
Favorable impact of an infection control network on nosocomial infection rates in community hospitals. Infect Control Hosp Epidemiol (2006) 1.08
Emergence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States? Clin Infect Dis (2009) 1.07
Increasing rates of methicillin-resistant Staphylococcus aureus in academic hospitals: a result of active surveillance? Infect Control Hosp Epidemiol (2013) 1.06
Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol (2011) 1.06
High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays. Anal Biochem (2006) 1.05
Observing and improving hand hygiene compliance: implementation and refinement of an electronic-assisted direct-observer hand hygiene audit program. Infect Control Hosp Epidemiol (2012) 1.04
Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate. J Biol Chem (2007) 1.04
Scrub typhus and rickettsial diseases in international travelers: a review. Curr Infect Dis Rep (2009) 1.02
Complex surgical site infections and the devilish details of risk adjustment: important implications for public reporting. Infect Control Hosp Epidemiol (2008) 1.02
Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States. Antimicrob Agents Chemother (2013) 1.00
Poor functional status is an independent predictor of surgical site infections due to methicillin-resistant Staphylococcus aureus in older adults. J Am Geriatr Soc (2010) 0.99
Risk factors for surgical site infections in older people. J Am Geriatr Soc (2006) 0.99
Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis (2006) 0.98
Methicillin-resistant Staphylococcus aureus outbreak in an intensive care nursery: potential for interinstitutional spread. Pediatr Infect Dis J (2007) 0.97
Risk factors for 1-year mortality after postoperative mediastinitis. J Thorac Cardiovasc Surg (2006) 0.95
Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol (2013) 0.94
Casablanca redux: we are shocked that public reporting of rates of central line-associated bloodstream infections are inaccurate. Infect Control Hosp Epidemiol (2012) 0.93
Development of mammalian serum albumin affinity purification media by peptide phage display. Biotechnol Prog (2002) 0.93
Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedure. Infect Control Hosp Epidemiol (2010) 0.93
Rickettsialpox in North Carolina: a case report. Emerg Infect Dis (2002) 0.92
Drugs derived from phage display: from candidate identification to clinical practice. MAbs (2014) 0.91
Surgical volume and the risk of surgical site infection in community hospitals: size matters. Ann Surg (2008) 0.91
Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases. Clin Infect Dis (2010) 0.91
Multidrug-resistant chronic osteomyelitis complicating war injury in Iraqi civilians. J Trauma (2011) 0.91
Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. Am J Infect Control (2008) 0.90
Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation (2003) 0.90